Abstract
In order to examine antioxidant status and lipid peroxidation in schizophrenia patients, activities of three free radical scavenging enzymes (superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and catalase (CAT)), and the level of thiobarbituric acid-reactive substances (TBARS) as an index of lipid peroxidation have been studied in red blood cells. Schizophrenic patients were divided into three groups (disorganized (n = 21), paranoid (n = 26) and residual types (n = 18)) to determine differences between subgroups. SOD, CAT and GSH-Px activities in the control group were found to be 1461.0 ± 248.6 U g−1 Hb, 148.2 ± 59.3 k g−1 Hb and 25.87 ± 4.25 U g−1 Hb, respectively. We found no significant differences in SOD activities between study and control groups. There was a significant increase in SOD activity in the residual group compared to the paranoid group (P < 0.005). CAT activity was found to be increased in disorganized (148%), paranoid (147%), and residual (165%) groups compared to the control group. GSH-Px activity was markedly increased in the study groups except the paranoid group. Statistically significant (3–4 fold) increases in TBARS levels of red blood cells were found in all the study groups. It is proposed that antioxidant status may be changed in schizophrenia and thus may induce lipid peroxidation. Therefore, oxidative stress may have a pathophysiological role in all the subtypes of schizophrenia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Esterbauer H . Cytotoxicity and genotoxicity of lipid-oxidation products Am J Clin Nutr 1993 57: (5 Suppl) 779–785
Fridovich I . Superoxide radical: an endogenous toxicant Annu Rev Pharmacol Toxicol 1983 23: 239–257. [Review]
Mahadik SP, Mukherjee S . Free radical pathology and antioxidant defense in schizophrenia: a review Schizophr Res 1996 19: 1–17. [Review]
Jiang HK, Wang YY . Diurnal melatonin and cortisol secretion profiles in medicated schizophrenic patients J Formos Med Assoc 1998 97: 830–837
Edgar PF, Douglas JE, Cooper GJ, Dean B, Kydd R, Faull RL . Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia Mol Psychiatry 2000 5: 85–90
Yao JK, Reddy R, McElhinny LG, van Kammen DP . Effects of haloperidol on antioxidant defense system enzymes in schizophrenia J Psychiatr Res 1998 32: 385–391
Rachkauskas GS . The level of lipid peroxidation and the function of the antioxidant system in different forms of schizophrenia Lik Sprava 1998 5: 92–93. [Russian]
Yamada K, Kanba S, Anamizu S, Ohnichi K, Ashikari J, Yagi G, Asai M . Low superoxide dismutase in schizophrenic patients with tardive dyskinesia Psychol Med 1997 27: 1223–1225
Mukerjee S, Mahadik SP, Scheffer R, Correnti EE, Kelkar H . Impaired antioxidant defense at the onset of psychosis Schizophr Res 1996 19: 19–26
Overall JE, Gorhan DR . The brief psychiatric rating scale Psychol Reports 1962 10: 799–812
Aebi H. Catalase . In: Bergmeyer HU (ed). Methods of Enzymatic Analysis Academic Press: New York and London 1974 pp 673–677
Sun Y, Oberley LW, Li Y . A simple method for clinical assay of superoxide dismutase Clin Chem 1988 34: 497–500
Durak I, Yurtarslani Z, Canbolat O, Akyol O . A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction Clin Chim Acta 1993 214: 103–104
McCord JM, Fridovich I . Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein) J Biol Chem 1969 244: 6049–6055
Paglia DE, Valentine WN . Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase J Lab Clin Med 1967 70: 158–170
Wasowicz W, Neve J, Peretz A . Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage Clin Chem 1993 39: 2522–2526
Reddy R, Sahebarao MP, Mukherjee S, Murthy JN . Enzymes of the antioxidant defense system in chronic schizophrenic patients Biol Psychiatry 1991 30: 409–412
Michelson AM, Puget K, Durosay P, Bouneau JC . Clinical aspects of the dosage of erythrocuprein. In: Michelson AM, McCord JM, Fridovich I (eds) Superoxide and Superoxide Dismutase Academic Press: London 1977 pp 467–499
Abdalla DS, Monteiro HP, Oliveira JA, Bechara EJ . Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients Clin Chem 1986 32: 805–807
Sinet PM, Debray Q, Carmagnol F, Pelicier Y, Nicole A, Jerome H . Normal erythrocyte SOD values in two human diseases: schizophrenia and cystic fibrosis. In: Greenwald RA, Cohen G (eds) Oxy Radicals and Their Scavenger Systems. Vol II: Cellular and Medical Aspects Elsevier: New York 1983 pp 302–304
Buckman TD, Kling AS, Eiduson S, Sutphin MS, Steinberg A . Glutathione peroxidase and CT scan abnormalities in schizophrenia Biol Psychiatry 1987 22: 349–356
Whatley SA, Curti D, Das Gupta F, Ferrier IN, Jones S, Taylor C et al. Superoxide, neuroleptics and the ubiquinone and cytochrome b5 reductases in brain and lymphocytes from normals and schizophrenic patients Mol Psychiatry 1998 3: 227–237
Abdalla DS, Bechara EJ . The effect of chlorpromazine and Li2CO3 on the superoxide dismutase and glutathione peroxidase activities of rat brain, liver and erythrocytes Biochem Mol Biol Int 1994 34: 1085–1090
Buckman TD, Kling AS, Eiduson S, Sutphin MS, Steinberg A, Eiduson S . Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables Psychiatry Res 1990 31: 1–14
Yao JK, Reddy RD, van Kammen DP . Human plasma glutathione peroxidase and symptom severity in schizophrenia Biol Psychiatry 1999 45: 1512–1515
Jesberger JA, Richardson JS . Oxygen free radicals and brain dysfunction Int J Neurosci 1991 57: 1–17. [Review]
Tsai G, Goff DC, Chang RW, Flood J, Baer L, Coyle JT . Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia Am J Psychiatry 1998 155: 1207–1213
Sachdev P, Saharov T, Cathcart S . The preventative role of antioxidants (selegiline and vitamin E) in a rat model of tardive dyskinesia Biol Psychiatry 1999 46: 1672–1681
Elkashef AM, Wyatt RJ . Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E Schizophr Bull 1999 25: 731–740
Dorfman-Etrog P, Hermesh H, Prilipko L, Weizman A, Munitz H . The effect of vitamin E addition to acute neuroleptic treatment on the emergence of extrapyramidal side effects in schizophrenic patients: an open label study Eur Neuropsychopharmacol 1999 9: 475–477
Vatassery GT, Bauer T, Dysken M . High doses of vitamin E in the treatment of disorders of the central nervous system in the aged Am J Clin Nutr 1999 70: 793–801
Keshavan MS, Mallinger AG, Pettegrew JW, Dippold C . Erythrocyte membrane phospholipids in psychotic patients Psychiatry Res 1993 49: 89–95
Horrobin DF, Manku MS, Hillman S, Iain A, Glen M . Fatty acid levels in brains of schizophrenics and normal controls Biol Psychiatry 1991 30: 795–805
Yao JK, Yasei P, van Kammen DP . Increased turn-over of platelet phosphatidylinositol in schizophrenia Prostaglandins Leukot Essent Fatty Acids 1992 46: 39–46
Yao JK, van Kammen DP, Welker JA . Red blood cell membrane dynamics in schizophrenia. I. Membrane fluidity Schizophr Res 1994 11: 209–216
Yao JK, van Kammen DP, Welker JA . Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition Schizophr Res 1994 13: 217–226
Yao JK, van Kammen DP . Incorporation of [3H] arachidonic acid into platelet phospholipids of patients with schizophrenia Prostaglandins Leukot Essent Fatty Acids 1996 55: 21–26
Yao JK, van Kammen DP, Gurklis J . Abnormal incorporation of arachidonic acid into platelets of drug-free patients with schizophrenia Psychiatry Res 1996 60: 11–21
Yao JK, Leonard S, Reddy RD . Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients Schizophr Res 2000 42: 7–17
Fenton WS, Hibbeln J, Knable M . Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia Biol Psychiatry 2000 47: 8–21
Maes M, Smith RS . Fatty acids, cytokines and major depression (editorial) Biol Psychiatry 1998 43: 313–314
Salem N Jr . Alcohol, fatty acids and diet Alcohol Health Res World 1989 13: 211–218
Nilsson A, Horrobin DF, Rosengren A, Waller L, Adlerberth A, Wilhelmsen L . Essential fatty acids and abnormal involuntary movements in the general male population: a study of men born in 1933 Prostaglandins Leukot Essent Fatty Acids 1996 55: 83–87
Martinez M, Vasquez E . MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders Neurology 1998 51: 26–32
Gattaz WF, Schmitt A, Maras A . Increased platelet phospholipase A2 activity in schizophrenia Schizophr Res 1995 16: 1–6
Gattaz WF, Kollish M, Thuren T, Virtanen JA, Kunnunen PKJ . Increased plasma phospholipase-A activity in schizophrenic patients: reduction after neuroleptic therapy Biol Psychiatry 1987 22: 421–426
Mathe AA, Sedvall G, Wiesel FA, Nyback H . Increased content of immunoreactive prostaglandin E in cerebrospinal fluid of patients with schizophrenia Lancet 1980 1: 16–18
Kaiya H, Uematsu M, Ofuji M, Nishida A, Takeuchi K, Nozaki M et al. Elevated plasma prostaglandin E2 levels in schizophrenia J Neural Transm 1989 77: 39–46
Linnoila M, Whorton R, Rubinow DR, Cowdry RW, Ninan PT, Waters RN . CSF prostaglandin levels in depressed and schizophrenic patients Arch Gen Psychiatry 1983 40: 405–406
Gerner R, Merrill J . Cerebrospinal fluid prostaglandin E in depression, mania, and schizophrenia compared to normals Biol Psychiatry 1983 18: 565–569
Mahadik SP, Scheffer RE . Oxidative injury and potential use of antioxidants in schizophrenia Prostglandins Leukot Essent Fatty Acids 1996 55: 45–54
Evans PH . Free radicals in brain metabolism and pathology Br Med Bull 1993 49: 577–587
Beauclair L, Vinogradov S, Riney SJ, Csernansky JG, Hollister LE . An adjunctive role for ascorbic acid in the treatment of schizophrenia? J Clin Psychopharmacol 1987 7: 282–283
Kanofsky JD, Sandyk R . Antioxidants in the treatment of schizophrenia Int J Neurosci 1992 62: 97–100. [Letter]
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Herken, H., Uz, E., Özyurt, H. et al. Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Mol Psychiatry 6, 66–73 (2001). https://doi.org/10.1038/sj.mp.4000789
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000789
Keywords
This article is cited by
-
Impact of silver ions and silver nanoparticles on biochemical parameters and antioxidant enzyme modulations in Saccharomyces cerevisiae under co-exposure to static magnetic field: a comparative investigation
International Microbiology (2023)
-
N-acetylcysteine prevents olanzapine-induced oxidative stress in mHypoA-59 hypothalamic neurons
Scientific Reports (2020)
-
Comparative study on the toxic mechanisms of medical nanosilver and silver ions on the antioxidant system of erythrocytes: from the aspects of antioxidant enzyme activities and molecular interaction mechanisms
Journal of Nanobiotechnology (2019)
-
Serum Oxidative Stress Marker Levels in Unmedicated and Medicated Patients with Schizophrenia
Journal of Molecular Neuroscience (2018)
-
Protective Potential of the Glutathione Peroxidase-1 Gene in Abnormal Behaviors Induced by Phencyclidine in Mice
Molecular Neurobiology (2017)